HepaRegeniX raised €21.5m from Wellington Partners, Novo Holdings, Boehringer Ingelheim Venture Fund, and Vesalius Biocapital.
04 April 2025
04 April 2025
Total investments received (USD): 39.35M
Round value (USD): 23.2M
Company: HepaRegeniX
Related deals
AMSilk raised €22m in debt and €30m in post series C equity funding led by Athos, joined by insiders MIG Capital and Novo Holdings.
Investments
01 September 2025
Belgium
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain